SERPINH1 and pulmonary fibrosis: However, targeting HSP47 for thrombosis prevention or other therapeutic applications, like idiopathic pulmonary fibrosis (IPF), must take into account its essential role in collagen stability, as deficiency or inhibition of HSP47 can lead to severe skeletal defects, as observed in OI Type X.15